Literature DB >> 17395492

Reduced thalamic volume in first-episode non-affective psychosis: correlations with clinical variables, symptomatology and cognitive functioning.

Benedicto Crespo-Facorro1, Roberto Roiz-Santiáñez, José María Pelayo-Terán, José Manuel Rodríguez-Sánchez, Rocío Pérez-Iglesias, César González-Blanch, Diana Tordesillas-Gutiérrez, Andrés González-Mandly, Consuelo Díez, Vincent A Magnotta, Nancy C Andreasen, José Luis Vázquez-Barquero.   

Abstract

Structural studies have inconsistently shown the presence of thalamic volume differences in patients with schizophrenia. However, only a few studies have examined the relation between thalamic structure and clinical and cognitive variables in early phases of the illness. Thalamic volumes in right-handed minimally treated first episode patients with non-affective psychosis (N=61) relative to those of right-handed healthy comparison subjects (N=40) were measured. Thalamic volumes in the right and left hemispheres and total thalamic volume were automatically segmented and analyzed using BRAINS2. Analysis of covariance was used to control for intracranial volume. Clinical symptoms were assessed by total scores of BPRS, SAPS and SANS. The relationship between three cognitive dimensions (verbal learning and memory, speed processing/executive functioning and sustained attention/vigilance), and thalamic volume was evaluated. The impact of the duration of untreated illness, untreated psychosis and prodrome period in thalamic morphometry was also explored. Right, left, and total thalamic volumes of the patients with non-affective psychosis were significantly smaller than those of the healthy subjects. Larger thalamic volumes were associated with an earlier age of onset, a poorer cognitive functioning and a more severe negative symptomatology. Thalamic volumetric differences between patients with non-affective psychosis and healthy controls are already present at early phases of the illness. However, further investigations are warranted to fully clarify the relationship between those structural anomalies and clinical and cognitive outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17395492     DOI: 10.1016/j.neuroimage.2007.01.048

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  21 in total

Review 1.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

2.  Lack of gender influence on cortical and subcortical gray matter development in childhood-onset schizophrenia.

Authors:  Brian Weisinger; Deanna Greenstein; Anand Mattai; Liv Clasen; Francois Lalonde; Sara Feldman; Rachel Miller; Julia W Tossell; Nora S Vyas; Reva Stidd; Christopher David; Nitin Gogtay
Journal:  Schizophr Bull       Date:  2011-05-25       Impact factor: 9.306

Review 3.  The role of untreated psychosis in neurodegeneration: a review of hypothesized mechanisms of neurotoxicity in first-episode psychosis.

Authors:  Kelly K Anderson; Aristotle Voineskos; Benoit H Mulsant; Tony P George; Kwame J Mckenzie
Journal:  Can J Psychiatry       Date:  2014-10       Impact factor: 4.356

4.  Sleep correlates of cognition in early course psychotic disorders.

Authors:  Matcheri S Keshavan; Debra M Montrose; Jean M Miewald; Ripu D Jindal
Journal:  Schizophr Res       Date:  2011-07-02       Impact factor: 4.939

5.  Multivariate patterns of brain-cognition associations relating to vulnerability and clinical outcome in the at-risk mental states for psychosis.

Authors:  Nikolaos Koutsouleris; Christian Gaser; Katja Patschurek-Kliche; Johanna Scheuerecker; Ronald Bottlender; Petra Decker; Gisela Schmitt; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Journal:  Hum Brain Mapp       Date:  2011-08-30       Impact factor: 5.038

6.  Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer's disease.

Authors:  Casey E Krueger; David L Dean; Howard J Rosen; Cathra Halabi; Michael Weiner; Bruce L Miller; Joel H Kramer
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jan-Mar       Impact factor: 2.703

7.  Volumetric and shape analysis of the thalamus in first-episode schizophrenia.

Authors:  Denise M Coscia; Katherine L Narr; Delbert G Robinson; Liberty S Hamilton; Serge Sevy; Katherine E Burdick; Handan Gunduz-Bruce; Joanne McCormack; Robert M Bilder; Philip R Szeszko
Journal:  Hum Brain Mapp       Date:  2009-04       Impact factor: 5.038

8.  Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting.

Authors:  Meikei Leung; Charlton Cheung; Kevin Yu; Benjamin Yip; Pak Sham; Qi Li; Siew Chua; Grainne McAlonan
Journal:  Schizophr Bull       Date:  2009-09-16       Impact factor: 9.306

9.  Amygdala volume is reduced in early course schizophrenia.

Authors:  Alyson M Rich; Youngsun T Cho; Yanqing Tang; Aleksandar Savic; John H Krystal; Fei Wang; Ke Xu; Alan Anticevic
Journal:  Psychiatry Res Neuroimaging       Date:  2016-02-12       Impact factor: 2.376

10.  Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia.

Authors:  Yujiro Yoshihara; Genichi Sugihara; Hideo Matsumoto; John Suckling; Katsuhiko Nishimura; Takao Toyoda; Haruo Isoda; Kenji J Tsuchiya; Kiyokazu Takebayashi; Katsuaki Suzuki; Harumi Sakahara; Kazuhiko Nakamura; Norio Mori; Nori Takei
Journal:  Ann Gen Psychiatry       Date:  2008-12-22       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.